- Buys
- 0 of 4
- Three are needed, so it stays out of the basket. Investor D did not answer.
- GAAP free cash flow, twelve months to September 30, 2026
- $2.68B
- The company guides about $4.8B of adjusted free cash flow for 2026.
- Litigation and PFAS exit cash, nine months of 2026
- $1.58B
- Most of the gap between those two numbers, paid after tax.
- Water supplier PFAS settlement
- $10.5B to $12.5B
- Payments scheduled from 2024 through 2036.
Quality, decade-long holdingThe franchise is healing, but owners keep a 3.2% cash yield and an unpriced court outcome.
Deep value, balance sheet firstNormalized earnings support far less than the market cap. No margin of safety.
Macro and reflexivityA cash yield under the 10-year, in tightening credit, with the tail still open.
GrowthThe seat timed out and cast no vote.
Session of October 20, 2026. Investor D did not answer within the time limit, so three seats voted. The third-quarter figures were added to the sheet by hand from the results release 3M filed that morning. This is the committee's first review of 3M.
Bottom line
3M had a good quarter. GAAP operating margin rose to 23.7% from 22.2%, Safety and Industrial operating income rose 21%, and adjusted EPS guidance went up to $9.10 to $9.15 (8-K, Exhibit 99.1, October 20, 2026). No seat disputed it.
What they disputed is which cash flow belongs to owners. Adjusted free cash flow adds back litigation payments, and owners never see that money. On the GAAP number the shares carry a 3.2% cash yield against a 10-year Treasury at 5.09%. All three seats used the GAAP figure, and that choice decided the vote. As in our JOE review, the screen figure and the filed figure differ.
The first test is the September-quarter 10-Q, due by November 9, 2026. Its litigation note is where an AFFF personal injury settlement, the one claim with no number, would first appear.
The business in 60 seconds
3M reports three segments (10-Q, filed July 21, 2026). Safety and Industrial spans abrasives, adhesives, personal safety and, since this year, fire and rescue. It carried 55% of third-quarter segment operating income, at $960M. Transportation and Electronics, home of the optical connectivity products behind the Amazon agreement, posted $468M. Consumer, the Scotch and Post-it business, posted $300M (8-K, October 20, 2026). Health care left as Solventum on April 1, 2024.
No one controls the company. The proxy filed March 25, 2026, lists four institutional holders at 5.10% to 8.89% each. There is one share class. The chairman and the chief executive are the same person.
| Fiscal year | Revenue | Operating margin | Free cash flow | Diluted shares |
|---|---|---|---|---|
| 2021 | $35.4B | 20.9% | $5.9B | 585M |
| 2022 | $26.2B | 16.8% | $3.8B | 568M |
| 2023 | $24.6B | -43.5% | $5.1B | 554M |
| 2024 | $24.6B | 19.5% | $638M | 552M |
| 2025 | $24.9B | 18.6% | $1.4B | 541M |
From each year's 10-K on SEC EDGAR. 2021 revenue includes health care; later years do not. The 2023 loss is the $10.3B water settlement charge. Free cash flow is operating cash flow less capex.
What changed
- The quarter. GAAP sales were $6.6B, up 1.0%, with organic growth of 0.2%. Excluding PFAS products 3M stopped making in 2025, organic growth was 3.3%. Operating cash flow was $486M against $1,756M, after $894M of litigation payments (8-K, October 20, 2026).
- Guidance. Adjusted organic growth above 3.5%, adjusted operating cash flow of about $5.9B, capex of about $1.1B. Litigation payments are not guided.
- Amazon. A seven-year warrant over up to 3,162,015 shares, 0.6% of the count. 85% vests as Amazon's data center purchases build toward $6B (8-K, October 19, 2026).
- A new claim on the balance sheet. A venture with a private equity partner bought Madison Fire & Rescue for $1.95B. The partner can redeem after five years, and its $971M interest sits outside net debt (10-Q, filed July 21, 2026).
- The competitors. In the June quarter Corning grew revenue 16.6% in the optical market 3M is chasing, Honeywell 4.3% and Illinois Tool Works 6.1% (each company's 10-Q). 3M grew 2.5%.
The bull case on 3M
- The litigation bill is shrinking. After-tax payments were $3.83B in 2024 and $2.82B in 2025, and this year's nine-month pace annualizes near $2.1B (company reconciliation, 8-K).
- Two of the three big claims are bounded. The water deal has a range and a schedule. The earplug accrual fell to $1.9B at June 30 from $2.4B at year end (10-Q, Note 15).
- Margins are moving on cost and price. Quarterly sales rose 1.0% while operating income rose 7.7%.
- Dilution is tied to delivery. Amazon's warrant vests only as Amazon buys, and Corning's growth shows the demand exists.
The litigation cash drag is genuinely falling: $3,831M in 2024, $2,817M in 2025, $1,577M in nine months of 2026
Investor C, Sell, listing what it likes
The personal injury claims may settle at a figure the business absorbs easily, and that is plausible (opinion).
Investor A, Avoid, on how it could be wrong
The bear case on 3M
- Adjusted cash is not owner cash. 2025 adjusted free cash flow was $4.37B, GAAP free cash flow $1.40B. Litigation, paid in cash, was most of the difference.
- One claim has no number. AFFF personal injury cases are in a bellwether process, with nine in further discovery and no settlement on file. 3M does not expect insurance to cover its aggregate liabilities in full (10-Q, Note 15).
- Debt fills the gap. Over nine months, dividends and buybacks took $4.44B and acquisitions $1.91B, against GAAP free cash flow of $1.34B. Net borrowing rose $2.53B.
- The cushion is thin. Net debt is $9.85B against total equity of $4.17B.
- The growth story has not reached its segment. Transportation and Electronics operating income fell to $468M from $484M. China organic sales fell 10.7%.
I cannot buy a business whose ten-year owner earnings depend on a court outcome I cannot estimate, at a price that already assumes the outcome is benign.
Investor A, Avoid 7
This is a carry trade wearing a turnaround costume.
Investor C, Sell 6
A low multiple alone would not cure an unquantifiable liability.
Investor B, on what its entry would still need
Where the committee splits
It did not split. Three seats voted, none voted Buy, and the strongest objection is one two seats raised against themselves: the payments are shrinking on the record.
Is the litigation bill fading, or a fixed cost owners carry to 2036?
| Position | Seats | The figure it rests on |
|---|---|---|
| Fading, so GAAP cash converges on adjusted | A and C, against their own verdicts | Litigation cash $3.83B, $2.82B, $1.58B for nine months (8-K) |
| Structural, with one claim unpriced | A, B, C | Water payments through 2036; AFFF personal injury unsettled (10-Q, Note 15) |
What settles it. Full-year 2026 litigation cash in the 2026 annual report, filed by March 1, 2027. Investor A's line is $2.0B or less with GAAP free cash flow of at least $3.5B. Investor C's is $1.8B or less, with a 2027 schedule below $1.2B.
From the chair, to Investor A. Your own counter-case gets owner cash near $4B once the water and earplug payments run off. At what annual litigation payment in the 2026 10-K does the 3.2% GAAP yield stop being the right base for your verdict?
The verdicts match but the reasons do not. Investors A and B rest on the legal tail. Investor C rests on credit, with high-yield spreads 61 basis points wider in 30 days.
| Investor | Verdict | What breaks its thesis |
|---|---|---|
| A | Avoid 7 | An AFFF personal injury settlement or accrual of $4B or less, in the 10-Q due November 9, 2026, or the 2026 10-K. A bounded settlement moves it to Watch. |
| B | Avoid 8 | GAAP net income and free cash flow both above $7.0B in 2027 and 2028. A durable fall in legal cash with bounded exposure could move it toward Watch. |
| C | Sell 6 | High-yield spread at or below 2.71% for four weeks and fed funds at or below 3.38%, before the January 2027 results. Easing moves it toward Hold. |
| D | No response | No vote was cast. |
Valuation
What the price requires. This is our arithmetic, and the seats never saw it. We solve for the free cash flow growth that justifies the $83.72B market cap for ten years, then 3% a year, discounted at the 10-year yield plus 4.5 points, 9.59%. The script's base, free cash flow to June 30 of $3.98B, needs 6.9% a year, but that window drops the heavy litigation payments of early 2025. We reran it on GAAP free cash flow to September 30. That base needs 12.2% a year, with year three at $3.78B. At 8.59% it needs 9.8% and $3.55B. At 10.59% it needs 14.5% and $4.01B.
The GAAP yield is 2.8% on an enterprise value of about $94.5B, which counts net debt and the partner's stake, against the 10-year at 5.09%. On adjusted figures the price looks undemanding: the $4.8B guided for 2026 already clears the band.
Hatched bars are what the market cap needs on GAAP free cash flow. Seat bars weight each seat's scenarios by its own probabilities. Investor D gave none.
| Investor | Bear | Base | Bull | Weighted, year 3 | Against the price |
|---|---|---|---|---|---|
| A | 30%, $1.5B | 50%, $3.0B to $3.5B | 20%, $4.5B | $2.98B | below the band |
| B | 30%, $1.5B | 50%, $3.0B | 20%, $4.8B | $2.91B | below the band |
| C | 30%, $2.0B | 50%, $4.2B | 20%, $5.5B | $3.80B | inside the band |
Only the weighted column uses a midpoint, for Investor A's base range. All three modeled GAAP free cash flow after litigation, for 2029.
Two seats sit below the band and one inside it, and none reaches the adjusted guidance. Investor C is inside the band and still voted Sell, because it reads the adjusted-to-GAAP gap as contractual: "The market pays for the story, the cash pays the ten-year."
| Investor | Entry discipline |
|---|---|
| A | A trailing GAAP free cash flow yield of 7% or more while personal injury is open, or 5.5% once a bounded settlement is on file |
| B | At most 8.4 times conservatively normalized earnings, with legal exposure bounded |
| C | A trailing GAAP free cash flow yield 50 basis points over the 10-year, or 14 times forward adjusted EPS after an AFFF resolution inside reserves |
Comparables
| Company | Market cap | Growth last FY | Operating margin | P/E | FCF yield |
|---|---|---|---|---|---|
| 3M (MMM) | $83.5B | 1.5% | 18.6% | 27.9x | 4.8% |
| Honeywell (HON) | $66.5B | 7.8% | 21.7% | 8.1x | 6.0% |
| Illinois Tool Works (ITW) | $76.9B | 0.9% | 26.3% | 24.1x | 3.8% |
| Emerson (EMR) | $89.5B | 3.0% | n/a | 34.7x | 3.9% |
| Avery Dennison (AVY) | $13.3B | 1.1% | n/a | 18.9x | 8.0% |
| Corning (GLW) | $114.3B | 19.1% | 14.6% | 60.2x | n/a |
Each company's SEC filings and one market price, the same method on every row, on trailing figures to June 30, 2026. The 3M row uses the June share count and cash flow window.
Honeywell's P/E reflects June-quarter net income of $5.68B against $1.57B a year earlier, so we do not read it as a valuation. Illinois Tool Works earns a higher margin at a similar multiple. On June figures 3M's yield looks competitive. On September figures it is below every peer here that has one.
Key risks
Ordered from most to least severe, in our judgment. Raised by names the source.
| Risk | Why it matters | Raised by | First signal |
|---|---|---|---|
| High. AFFF personal injury liability | A second payment stream on top of the 2036 schedule | 10-Q Note 15; Analyst; Investors A, B, C | A settlement, accrual or verdict in an 8-K or the litigation note |
| High. Payouts and deals funded with debt | Leverage rises while the tail is open | Analyst; Investors A, B, C | Net debt at December 31, 2026, against $9.85B |
| Medium. Credit tightening | Refinancing $2.44B of current debt at wider spreads | Investor C; desk arithmetic | High-yield spread above 3.31% |
| Medium. China and trade policy | Tariffs, export controls and weak China demand | 10-K Item 1A; Analyst; Investors A, B, C | China organic growth in the next release |
| Medium. Data center ramp falls short | The growth case rests on one segment and one customer | Analyst; Investors B, C | Warrant vesting in 10-Qs; segment operating income |
The filings settle one old worry, a dividend cut. It already happened: dividends paid fell from $3.4B in 2021 to $1.6B in 2025.
What to watch
| Date | Event | What it decides |
|---|---|---|
| November 9, 2026 | Third-quarter 10-Q, last day under SEC rules | AFFF status, the earplug accrual, the New Jersey ruling |
| March 1, 2027 | Annual 10-K for 2026, last day under SEC rules | Full-year litigation cash, GAAP free cash flow, year-end net debt |
| Ongoing | Any 8-K on an AFFF personal injury settlement or verdict | Whether the open claim gets a number |
| Ongoing | Amazon warrant vesting, in each 10-Q | Whether data center sales reach the segment |
Owning it onchain
Two tokenized versions exist. Backpack's MMM.US is not investable: it is not verified on Jupiter. We have not judged xStocks' MMMx: when we checked, before regular US trading opened on October 20, 2026, no market maker was quoting it.
Data
| Item | Figure | Source |
|---|---|---|
| Price | $162.01, October 19, 2026 close | Yahoo Finance |
| Shares outstanding | 516,729,574 at September 30, 2026 | Balance sheet, 8-K Exhibit 99.1, October 20, 2026 |
| GAAP free cash flow, twelve months | $2.68B to September 30, 2026 | The FY2025 10-K figure, minus the first nine months of 2025, plus the first nine months of 2026 (8-K) |
| Enterprise value | About $94.5B | Market cap plus net debt and the $971M redeemable interest |
Method. Four investors with different philosophies, each on a different AI model, read one identical fact sheet and voted independently. A name needs three Buys to enter a basket. How the committee works.
Correction. This article first said neither token was investable, counting a missing quote for MMMx taken before regular US trading opened as a failure. Market makers quote thinly or not at all at that hour. We now judge that cost only during regular US market hours, and we have removed that verdict.
As of October 20, 2026, BagsCapital manages no outside capital and holds no position in 3M. Nothing here is investment advice.